 Initial clinical trial EXOSURF protein-free synthetic surfactant prophylaxis early treatment hyaline membrane disease EXOSURF protein-free surfactant dipalmitoylphosphatidylcholine hexadecanol tyloxapol weight single dose mL EXOSURF kilogram body weight mg dipalmitoylphosphatidylcholine kilogram body weight mL/kg air controlled trials birth neonates prophylactic trial hours birth neonates hyaline membrane disease severe mechanical ventilation rescue trial studies time-averaged inspired oxygen concentrations airway pressures hours entry treated neonates control neonates Thirty-six percent treated neonates rescue study incomplete response treatment hours need retreatment neonates rescue trial risk-adjusted survival treated group significant differences intracranial hemorrhages chronic lung disease symptomatic patent ductus arteriosus control infants trial